[1]
Clayton, R., Wu, J., Heng, D.Y., North, S.A., Emmenegger, U., Hotte, S., Chi, K., Zielinski, R., Al-Shamsi, H., Chen, L. and Eigl, B. 2014. A multicentre analysis of abiraterone acetate in Canadian patients with metastatic castration resistant prostate cancer. Canadian Urological Association Journal. 8, 9-10 (Sep. 2014), e583–90. DOI:https://doi.org/10.5489/cuaj.1891.